Golden
Cepheid Inc

Cepheid Inc

Cepheid Inc. is a molecular diagnostics company that looks to provide molecular systems and tests for genetic-bases diseases as well as organism based diseases.

Cepheid Inc. is a molecular diagnostics company that looks to provide molecular systems and tests for genetic-bases diseases as well as organism based diseases. The company was founded by Allen Northrup, Dennis Giesing, and Steve Young, in 1996, in Sunnyvale, California, United States.

The company looks to provide a molecular platform for healthcare leaders, institutions, medical clinics, laboratories, and hospitals. Their tests cover various clinical applications including healthcare-associated infections, sexual health, critical infectious disease, virology, and oncology.

COVID-19

Since the outbreak of COVID-19 (coronavirus), Cepheid has partnered with Sherlock Biosciences to develop a concept project that detects SARS-CoV-2 coronavirus as a first initiative of a broader collaboration to developing molecular diagnostic tests for infectious diseases and oncology. The molecular test will use CRISPR technology and the SHERLOCK platform.

Their collaboration looks to pursue a broad set of solutions for clinical and non-clinical coronavirus solutions. The company looks to deal with infections, critical and non-critical, and oncology that is associated with coronavirus. The company has also partnered with GeneXpert to find solutions for diseases.

On March 21, received emergency use authorization from the FDA for a COVID-19 test. The test is a PCR test that runs in 45 minutes and uses a cartridge and is run on Cepheid’s GeneXpert Systems. The automated systems do not require users to have special training and there is less than a minute of hands on time. There are 23,000 GeneXpert Systems worldwide and 5000 in the US.

Timeline

Funding rounds

Funding round
Description
Funding round amount (USD)
Funding type
Funding round date
Investment
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Aashish Rathod

Employee

Abhinav Koppu

Employee

Adam Baybutt

Employee

Alex Henderson

Employee

Alym Dowell

Employee

Amanda Radford

Employee

Ana Villa

Employee

Andrew Atwell

Employee

Anh Chu

Employee

Anna Rodriguez

Employee

Anna Sola Espona

Employee

Annemarie Davis

Employee

Annette Mahaffey

Employee

Aparna Venkatramani

Employee

Benjamin Sfard

Employee

Bhagyashree Nigudkar

Employee

Bradley Braithwaite

Employee

Brian Kutner

Employee

Calvin Nguyen

Employee

Carlos Perez

Employee

SHOW MORE (128)

Further reading

Title
Author
Link
Type
Date

Cepheid | Enabling Access to Molecular Diagnostic Testing Everywhere

Web

Cepheid, Sherlock to Develop Coronavirus Test, Part of Broader MDx Collaboration

Web

March 2, 2020

Review of use of a new rapid real-time PCR, the Cepheid GeneXpert® (Xpert) CT/NG assay, for Chlamydia trachomatis and Neisseria gonorrhoeae: result... - PubMed - NCBI

pubmeddev, Gaydos CA

Web

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services

Cepheid

Dennis Giesing

Sunnyvale, California, United States

Molecular Diagnostic Tests

References